Therapies that unleash the immune system to fight tumors have greatly extended the lives of people with many types of cancer.

Researchers have discovered that 'DEAD-box helicases 54 (DDX54)', a type of RNA-binding protein, is the master regulator that hinders the effectiveness of immunotherapy -- opening a new path for lung ...

Black patients with metastatic triple-negative breast cancer received immunotherapy less frequently than patients of other ...

Brian McNamara has a shot at beating his aggressive cancer, but his Aetna subsidiary insurance company doesn't want to pay ...

About 65% of melanoma patients do not respond to immunotherapy. New work by the team of Prof. Max Mazzone (VIB-KU Leuven ...

A week after President Trump instituted broad tariffs on imports during his “Liberation Day,” he abruptly announced yesterday ...

Teddi Mellencamp shared on her podcast, "Two Ts in a Pod," her father, musician John Mellencamp, called to ask her if she ...

Real world data show that immunotherapy leads to better overall survival outcomes than chemotherapy in patients with ...

The “RHOBH” alum previously revealed that she and her dad spoke about where she would be buried if she were to succumb to her battle with cancer.

Use of immune checkpoint inhibitors in an inpatient setting appeared associated with poor outcomes, according to research ...

Teddi Mellencamp revealed that her dad, John Mellencamp, has already started planning her burial amid her battle with stage ...

A new form of tumor infiltrating lymphocyte (TIL) therapy, a form of personalized cancer immunotherapy, dramatically improved the treatment's effectiveness in patients with metastatic gastrointestinal ...